Autosomal dominant axonal hereditary motor and sensory polyneuropathy caused by a mutation in the LRSAM1 gene (HMSN type 2P)
DOI:
https://doi.org/10.5281/zenodo.16884144Keywords:
CMT, HMCH, LRSAM1Abstract
To date, more than 80 genes associated with Charcot-Marie-Tooth disease (CMT), also called hereditary motor and sensory neuropathy (HMSN), have been described. Mutations in the LRSAM1 gene have been identified as a rare cause and define the axonal hereditary motor and sensory neuropathy type 2P subgroup. We present two patients from 1 family identified with the pathogenic variant c.2011C>T (p.Gln671Ter) in the LRSAM1 gene. Clinical and electrophysiological data confirm a late-onset axonal neuropathy with a predominance of sensorimotor impairment. In conclusion, HMSN type 2P is a rare axonal neuropathy with an autosomal dominant mode of inheritance with onset in adulthood.
References
Aerts MB, Weterman MAJ, Quadri M, Schelhaas HJ, Bloem BR, Esselink RA, et al. A LRSAM1 mutation links Charcot-Marie-Tooth type 2 to Parkinson’s disease. Ann Clin Transl Neurol 2016;3:146–9.
Bacquet J, Stojkovic T, Boyer A, Martini N, Audic F, Chabrol B, et al. Molecular diagnosis of inherited peripheral neuropathies by targeted next-generation sequencing: molecular spectrum delineation. BMJ Open 2018;8:e021632.
Cortese, J.E. Wilcox, J.M. Polke, et al., Targeted next-generation sequencing panels in the diagnosis of Charcot-Marie-Tooth disease, Neurology 94 (1) (2020) e51–e61.
Dohrn MF, Glöckle N, Mulahasanovic L, Heller C, Mohr J, Bauer C, et al. Frequent genes in rare diseases: panel-based next generation sequencing to disclose causal mutations in hereditary neuropathies. J Neurochem 2017;143:507–22.
Engeholm M, Sekler J, Schöndorf DC, Arora V, Schittenhelm J, Biskup S, et al. A novel mutation in LRSAM1 causes axonal Charcot-Marie-Tooth disease with dominant inheritance. BMC Neurol 2014;14:118.
Fogel BL, Lee H, Deignan JL, Strom SP, Kantarci S, Wang X, et al. Exome sequencing in the clinical diagnosis of sporadic or familial cerebellar ataxia. JAMA Neurol 2014;71:1237.
Guernsey DL, Jiang H, Bedard K, Evans SC, Ferguson M, Matsuoka M, et al. Mutation in the gene encoding ubiquitin ligase LRSAM1 in patients with Charcot-Marie-Tooth disease. PLoS Genet 2010;6:e1001081.
Hakonen JE, Sorrentino V, Avagliano Trezza R, de Wissel MB, van den Berg M, Bleijlevens B, et al. LRSAM1-mediated ubiquitylation is disrupted in axonal Charcot-Marie-Tooth disease 2P. Hum Mol Genet 2017;26:2034–41.
Hsu Y, Lin K, Guo Y, Tsai Y, Liao Y, Lee Y. Mutation spectrum of Charcot-Marie-Tooth disease among the Han Chinese in Taiwan. Ann Clin Transl Neurol 2019 acn3.50797.
Hu B, Arpag S, Zuchner S, Li J. A novel missense mutation of CMT2P alters transcription machinery: novel CMT2P Mutation. Ann Neurol 2016;80:834–45.
Laššuthová P, Šafka Brožková D, Kr˚ utová M, Neupauerová J, Haberlová J, Mazanec R, et al. Improving diagnosis of inherited peripheral neuropathies through gene panel analysis. Orphanet J Rare Dis 2016;11:118. 132P. Reilich, B. Schlotter, F. Montagnese et al.
Lupo V, García-García F, Sancho P, Tello C, García-Romero M, Villarreal L, et al. Assessment of targeted next-generation sequencing as a tool for the diagnosis of charcot-marie-tooth disease and hereditary motor neuropathy. J Mol Diagn 2016;18:225–34.
Mortreux J, Bacquet J, Boyer A, Alazard E, Bellance R, Giguet- Valard AG, et al. Identification of novel pathogenic copy number variations in Charcot-Marie-Tooth disease. J Hum Genet 2020;65:313– 23.
Nicolaou P, Cianchetti C, Minaidou A, Marrosu G, Zamba- Papanicolaou E, Middleton L, et al. A novel LRSAM1 mutation is associated with autosomal dominant axonal Charcot-Marie-Tooth disease. Eur J Hum Genet 2013;21:190–4.
P. Palaima, J. Berciano, K. Peeters, A. Jordanova, LRSAM1 and the RING domain: Charcot–Marie–tooth disease and beyond, Orphanet J. Rare Dis. 16 (1) (2021) 74.
Peddareddygari LR, Oberoi K, Vellore JR, Grewal RP. Factors affecting phenotype variability in a family with CMT2B: gender and LRSAM1 genotype. Case Rep Neurol 2016;8:120–6.
Peeters K, Palaima P, Pelayo-Negro AL, García A, Gallardo E, García- Barredo R, et al. Charcot-Marie-Tooth disease type 2G redefined by a novel mutation in LRSAM1. Ann Neurol 2016;80:823–33.
Peretti A, Perie M, Vincent D, Bouhour F, Dieterich K, Mallaret M, et al. LRSAM1 variants and founder effect in French families with ataxic form of Charcot-Marie-Tooth type 2. Eur J Hum Genet 2019;27:1406–18.
Retterer K, Juusola J, Cho MT, Vitazka P, Millan F, Gibellini F, et al. Clinical application of whole-exome sequencing across clinical indications. Genet Med 2016;18:696–704.
S. Nambot, A. Masurel, S. El Chehadeh, et al., 9q33.3q34.11 microdeletion: new contiguous gene syndrome encompassing STXBP1, LMX1B and ENG genes assessed using reverse phenotyping, Eur. J. Hum. Genet 24 (6) (2016) 830–837.
Trujillano D, Bertoli-Avella AM, Kumar Kandaswamy K, Weiss ME, Köster J, Marais A, et al. Clinical exome sequencing: results from 2819 samples reflecting 1000 families. Eur J Hum Genet 2017;25:176–82.
Wang W, Wang C, Dawson DB, Thorland EC, Lundquist PA, Eckloff BW, et al. Target-enrichment sequencing and copy number evaluation in inherited polyneuropathy. Neurology 2016;86:1762–71.
Weterman MAJ, Sorrentino V, Kasher PR, Jakobs ME, van Engelen BGM, Fluiter K, et al. A frameshift mutation in LRSAM1 is responsible for a dominant hereditary polyneuropathy. Hum Mol Genet 2012;21:358–70.
Zhao G, Song J, Yang M, Song X, Liu X. A novel mutation of LRSAM1 in a Chinese family with Charcot-Marie-Tooth disease: a novel mutation of LRSAM1 in a Chinese family with Charcot-Marie-Tooth disease. J Peripher Nerv Syst 2018;23:55–9.
Downloads
Published
How to Cite
Issue
Section
ARK
License
Copyright (c) 2025 Ognyan Asenov, Teodora Chamova, Albena Jordanova, Ivaylo Tournev
This work is licensed under a Creative Commons Attribution 4.0 International License.
